← Browse by Condition
Medical Condition
angiosarcoma
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, Phase 1, Phase 1, Phase 2
NCT06898970 Phase 2
Recruiting
Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma
Enrollment
18 pts
Location
United States
Sponsor
Varun Monga, MBBS
NCT06440005 Phase 1
Recruiting
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Enrollment
80 pts
Location
United States
Sponsor
Angiex, Inc.
NCT06277154 Phase 2
Recruiting
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
Enrollment
148 pts
Location
China
Sponsor
HRYZ Biotech Co.
NCT06239272 Phase 1, Phase 2
Recruiting
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Enrollment
139 pts
Location
United States
Sponsor
St. Jude Children's Research H...
NCT07432932
Recruiting
Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients
Enrollment
800 pts
Location
United Kingdom
Sponsor
Royal Marsden NHS Foundation T...